top of page
Peptide Patch Store
🔴Ipamorelin / CJC-1295 No Dac | 5/5mg Blend
Product Details
Brand:
MicroPharma.us
IPAMORELIN / CJC-1295 NO DAC BLEND
| Ipamorelin | CJC-1295 No Dac | |
| Unit Size 10mg | 5mg | 5mg |
| Unit Quantity | 1/2 Vial | 1/2 Vial |
| Molecular Formula | C38H49N9O5 | C152H252N44O42 |
| Molecular Weight | 711.9 | 3367.9 |
| Sequence | H-Aib-His-D-2Nal-D-Phe-Lys-NH2 | H-DL-Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xiIle-DL-Phe-DL-xiThr-DL-Gln-DL-Ser-DL-Tyr-DL-Arg-DL-Lys-DL-Val-DL-Leu-DL-Ala-DL-Gln-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-Lys-DL-Leu-DL-Leu-DL-Gln-DL-Asp-DL-xiIle-DL-Leu-DL-Ser-DL-Arg-NH2 |
| Appearance | White Powder | White Powder |
| Peptide Purity | >98.1% | >98.1% |
| Solubility | Soluble in water or 1% acetic acid | Soluble in water or 1% acetic acid |
The combination of Ipamorelin and CJC-1295 No DAC represents a significant advancement in the realm of growth hormone-releasing peptides, delivering a powerful and synergistic method to boost growth hormone (GH) secretion and promote a more youthful biological environment. This innovative blend merges the selective GH secretagogue properties of Ipamorelin with the modified growth hormone-releasing factor (GRF) analog characteristics of CJC-1295 No DAC. Together, they aim to enhance the natural, pulsatile release of GH from the anterior pituitary gland, effectively mimicking the body’s own GH release rhythms for maximum benefit.
Ipamorelin stands out for its targeted approach, engaging the ghrelin receptor with high affinity and specificity. This leads to GH release without inducing the unwanted increases in cortisol or acetylcholine commonly associated with other GH secretagogues. The result is a more refined activation of the GH axis, which is particularly appealing for those looking to enjoy the anabolic and rejuvenating effects of increased GH levels without adverse effects.
CJC-1295 No DAC contributes by prolonging the activity of endogenous GRF, thanks to modifications that make it more resistant to enzymatic breakdown. This leads to a more extended GH release pattern, enhancing overall GH exposure and amplifying the effects of Ipamorelin. The exclusion of DAC (Drug Affinity Complex) from this formula ensures that GH release more closely resembles the body’s natural regulatory processes.
By combining Ipamorelin and CJC-1295 No DAC into a single formulation, the regimen becomes simpler for the user, reducing both the complexity and the cost associated with GH therapy. This blend is not just a matter of convenience but a strategic enhancement of GH therapy, intended to generate a strong, yet balanced GH release pattern. This approach supports muscle development, fat reduction, faster recovery, and the extensive anti-aging benefits linked to increased GH levels, presenting a forward-thinking strategy for biohacking and age management with unmatched convenience and effectiveness.
Please be aware that the information provided is based on scientific research and is for educational and informational purposes only. These are the subjects of ongoing studies to further understand their potential and applications. Individuals should consult healthcare professionals before considering any peptide for therapeutic use.
OFFICIAL PARTNERS:
bottom of page